Glaucoma
AIAI is revolutionizing the treatment of glaucoma – the world’s second leading cause of blindness
AI identifies HG9-91-01 as a promising treatment for acute glaucoma, offering neuroprotection and preserving vision by targeting RIPK3.
Rebecca Shavit